Global Avobenzone Market Outlook 2017-2022

Published: Jul, 2017 | Pages: 100 | Publisher: Gen Consulting Company
Industry: Chemicals | Report Format: Electronic (PDF)

Avobenzone is the most important UVA absorber that has been globally approved. Avobenzone (EU) (formally 4-tert-butyl-4'-methoxydibenzoylmethane, or butyl methoxydibenzoylmethane) was patented in 1973 and commercialized by Hoffman LaRoche as Parsol 1789. It was approved as a monographed sunscreen in the EU (up to 5%) in 1978 and by the FDA (up to 3%) in 1996. It is an oil-soluble, crystalline UVA sunscreen (EU) with a melting point of 81-86 C. Avobenzone has an absorption maximum of 357 nm and a UV absorption value (1% / 1 cm in methanol (EU) at 358 nm) of 1100 - 1160.

The report covers forecast and analysis for the avobenzone market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the avobenzone market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the avobenzone market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global avobenzone market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the avobenzone market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.

Key Regions
• North America
• Europe
• Asia Pacific
• China

Key Vendors
• Merck
• COSMOS
• Symrise
• MFCI
• Vivimed

Key Questions Answered in this Report
• What will the market size be in 2022?
• What are the key factors driving the global avobenzone market?
• What are the challenges to market growth?
• Who are the key players in the avobenzone market?
• What are the market opportunities and threats faced by the key players?

 Table of Contents

Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Product Overview
3.4 Manufacturing Process
3.3 Raw Materials
3.4 Cost Analysis

Part 4. Competitive Landscape
4.1 Global Avobenzone Market, by Volume 2012-2017
4.1.1 Overview
4.1.2 Global Avobenzone Market, by Volume, by Company
4.1.3 Top 3 Companies by Volume Share
4.2 Global Avobenzone Market, by Revenue 2012-2017
4.2.1 Overview
4.2.2 Global Avobenzone Market, by Revenue, by Company
4.2.3 Top 3 Companies by Revenue Share

Part 5. Market Dynamics
5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

Part 6. North America
6.1 North American Avobenzone Market Size
6.2 by Country
6.2.1 United States
6.2.2 Canada

Part 7. Europe
7.1 European Avobenzone Market Size
7.2 by Country
7.2.1 Germany
7.2.2 UK
7.2.3 France

Part 8. Asia-Pacific
8.1 Asia-Pacific Avobenzone Market Size
8.2 by Country
8.2.1 China
8.2.2 Japan
8.2.3 India

Part 9. Avobenzone Market Forecast
9.1 Global Avobenzone Market Size 2017-2022
9.2 Global Avobenzone Market by Region 2017-2022
9.2.1 North America
9.2.2 Europe
9.2.3 Asia-Pacific

Part 10. Company Profiles
10.1 Merck
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Financials
10.2 COSMOS
10.3 Symrise
10.4 MFCI
10.5 Vivimed
...

Part 11. Industry Activity
11.1 M&As, JVs and Partnership
11.2 Expansions
11.3 Other Developments

Part 12. Appendix
12.1 Abbreviations
12.2 Disclaimer